Diagnostic Biomarker
Diagnostic Biomarker - Related Videos
08:29
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
0 Views •
Cited by 29 •
2012
We describe a rat model of post traumatic stress disorder (PTSD) that reveals the persistent alterations in neuroendocrine function and the delayed long-term, exaggerated fear response, characteristic of PTSD patients. The animal model and methods described here are useful for correlating biomarkers in brain nuclei, which are mechanistic but cannot be measured in patients, with biomarkers in peripheral white blood cells, which can.
04:33
CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
0 Views •
Cited by 3 •
2023
This protocol describes a CRISPR-Cas-mediated, multianalyte synthetic urine biomarker test that enables point-of-care cancer diagnostics through the ex vivo analysis of tumor-associated protease activities.
07:45
Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
0 Views •
Cited by 1 •
2025
This article describes a protocol for the collection and detection of miR-15a from tears as a new diagnostic tool for diabetic retinopathy.
10:21
Microfluidic Applications for Disposable Diagnostics
0 Views •
Cited by 1 •
2008
In this interview, Dr. Klapperich discusses the fabrication of thermoplastic microfluidic devices and their application for development of new diagnostics.
08:28
An Overview of bGDGT Biomarker Analysis for Paleoclimatology
0 Views •
2023
Source: Laboratory of Jeff Salacup - University of Massachusetts Amherst Throughout this series of videos, natural samples were extracted and purified in search of organic compounds, called biomarkers, that can relate information on climates and environments of the past. One of the samples analyzed was sediment. Sediments accumulate over geologic time in basins, depressions in the Earth into which sediment flows through the action of fluid (water or air), movement, and gravity. Two main types...
FAQs
Pathogen-derived components and host-response signals answer different biological questions. A pathogen marker can provide evidence tied directly to the infectious agent, whereas antibodies, cytokines, and other immune signals reflect how the patient responds. Considering either signal, or interpreting them as complementary evidence when supported by an assay, can help characterize infection and distinguish disease states.
Defined thresholds and reference patterns convert assay measurements into interpretable categories. A result is not useful merely because a biological signal is detectable; its level or pattern must be compared with the criteria established for that assay. This framework supports decisions about whether findings are consistent with disease, a particular disease state, or disease absence.
Different biomarker classes can provide information about the disease course. Pathogen-derived signals may support detection of infection, while host signals can reveal immune activity associated with disease status. Tracking these measurements over time can therefore contribute to assessment of progression and help show whether the biological state is changing.
Diagnostic biomarker research links measurement with host-pathogen biology. Detecting pathogen components addresses the presence of the infectious agent, while measuring antibodies, cytokines, or other immune signals reveals aspects of the host response. Comparing these types of evidence can help investigators study host-pathogen interactions while also improving interpretation of disease-related findings.
Immunology and infection assays can examine patient samples for pathogen-derived components or immune signals. Relevant targets include antibodies and cytokines, along with other measurable responses described by the assay. The practical workflow is to detect or quantify the selected feature, then interpret its value using a defined threshold or reference pattern rather than treating every measurement identically.
An assay-based decision process typically moves from sample analysis to biological interpretation and then to clinical use. Researchers first measure the selected marker, compare the result with established criteria, and use the resulting pattern to support a decision. This approach can help identify infection, distinguish disease states, or provide information for treatment-related assessment.
Repeated measurements can extend the role of a diagnostic biomarker beyond initial detection. Comparing results across time may help monitor disease progression or assess response to treatment, provided the measurements are interpreted with the assay’s established thresholds or reference patterns. Such use turns biomarker data into a way to follow changing clinical status rather than relying on one result.
At the population level, biomarker testing can support surveillance of emerging infectious diseases. Measurements from patient samples may reveal pathogen-associated findings or characteristic immune responses that contribute to recognition of disease patterns. This application complements individual clinical decision-making by using diagnostic information to strengthen awareness of changing infectious threats.